Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Peripheral CD39-expressing T regulatory cells are increased and associated with relapsing-remitting multiple sclerosis in relapsing patients
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-19
DOI
10.1038/s41598-019-38897-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment
- (2017) Anudeep B. Pant et al. JOURNAL OF NEUROIMMUNOLOGY
- Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis
- (2017) Jörg Friess et al. Scientific Reports
- Human CD39hi regulatory T cells present stronger stability and function under inflammatory conditions
- (2016) Jian Gu et al. Cellular & Molecular Immunology
- Phenotypical characterization of regulatory T cells in humans and rodents
- (2016) A. L. Rodríguez-Perea et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- iTreg induced from CD39+ naive T cells demonstrate enhanced proliferate and suppressive ability
- (2015) Yunjie Lu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation
- (2015) Anne Rissiek et al. JOURNAL OF AUTOIMMUNITY
- Regulatory T Cell–Derived Adenosine Induces Dendritic Cell Migration through the Epac-Rap1 Pathway
- (2015) Sabine Ring et al. JOURNAL OF IMMUNOLOGY
- Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse
- (2015) Nathalie GV Muls et al. Multiple Sclerosis Journal
- Regulation of Treg-associated CD39 in multiple sclerosis and effects of corticotherapy during relapse
- (2015) Nathalie GV Muls et al. Multiple Sclerosis Journal
- Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients
- (2014) Nathalie Muls et al. PLoS One
- An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling
- (2014) Yan Wang et al. Nature Communications
- Regulatory T cell proliferative potential is impaired in human autoimmune disease
- (2013) Fortunata Carbone et al. NATURE MEDICINE
- Stat3 and Gfi-1 Transcription Factors Control Th17 Cell Immunosuppressive Activity via the Regulation of Ectonucleotidase Expression
- (2012) Fanny Chalmin et al. IMMUNITY
- Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse
- (2011) Evelyn Peelen et al. JOURNAL OF NEUROIMMUNOLOGY
- T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients
- (2011) Dacia Dalla Libera et al. PLoS One
- ATP Inhibits the Generation and Function of Regulatory T Cells Through the Activation of Purinergic P2X Receptors
- (2011) U. Schenk et al. Science Signaling
- Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
- (2009) Verena Brucklacher-Waldert et al. BRAIN
- The activity and expression of NTPDase is altered in lymphocytes of multiple sclerosis patients
- (2009) Roselia M. Spanevello et al. CLINICA CHIMICA ACTA
- CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
- (2009) J. M. Fletcher et al. JOURNAL OF IMMUNOLOGY
- Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+CD25+FOXP3+CD31+ T-cells in patients with multiple sclerosis
- (2009) Juergen Haas et al. JOURNAL OF NEUROIMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now